Journal article · 2020 · Open access

Challenges in nanomedicine clinical translation

Josbert M. Metselaar, Twan Lammers

Drug Delivery and Translational Research, 10(3), 721–725 · Published 12 March 2020 · DOI 10.1007/s13346-020-00740-5

Open PDFView at the publisherCite this paper

In brief

“Challenges in nanomedicine clinical translation” is a 2020 journal article by Josbert M. Metselaar and Twan Lammers, published in Drug Delivery and Translational Research. OpenAlex counts 471 citations as of 20 November 2026. It is open access under a CC BY licence: the full text is free to read at Drug Delivery and Translational Research.

Citations
471
Most cited in
2026 (155)
Field-weighted impact
8.78
References
11
Authors
2

Abstract

New nanomedicine formulations and novel applications of nanomedicinal drugs are reported on an almost daily basis. While academic progress and societal promise continue to shoot for the stars, industrial acceptance and clinical translation are being looked at increasingly critically. We here discuss five key challenges that need to be considered when aiming to promote the clinical translation of nanomedicines. We take the perspective of the end-stage users and consequently address the developmental path in a top-down manner. We start off by addressing central and more general issues related to practical and clinical feasibility, followed by more specific preclinical, clinical, and pharmaceutical aspects that nanomedicinal product development entails. We believe that being more aware of the end user's perspective already early on in the nanomedicine development path will help to better oversee the efforts and investments needed, and to take optimally informed decisions with regard to market opportunities, target disease indication, clinical trial design, therapeutic endpoints, preclinical models, and formulation specifications. Critical reflections on and careful route planning in nanomedicine translation will help to promote the success of nanomedicinal drugs. Graphical abstract.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Metselaar, J. M., & Lammers, T. (2020). Challenges in nanomedicine clinical translation. Drug Delivery and Translational Research, 10(3), 721–725. https://doi.org/10.1007/s13346-020-00740-5

MLA 9

Metselaar, Josbert M., and Twan Lammers. “Challenges in nanomedicine clinical translation.” Drug Delivery and Translational Research, vol. 10, no. 3, 2020, pp. 721–725. https://doi.org/10.1007/s13346-020-00740-5.

Chicago

Metselaar, Josbert M. and Twan Lammers. 2020. “Challenges in nanomedicine clinical translation.” Drug Delivery and Translational Research 10 (3): 721–725. https://doi.org/10.1007/s13346-020-00740-5.

Harvard

Metselaar, J. M. and Lammers, T. (2020) ‘Challenges in nanomedicine clinical translation’, Drug Delivery and Translational Research, 10(3), pp. 721–725. doi:10.1007/s13346-020-00740-5.

IEEE

J. M. Metselaar and T. Lammers, “Challenges in nanomedicine clinical translation,” Drug Delivery and Translational Research, vol. 10, no. 3, pp. 721–725, 2020, doi: 10.1007/s13346-020-00740-5.

BibTeX

@article{metselaar2020challenges,
  title     = {{Challenges in nanomedicine clinical translation}},
  author    = {Metselaar, Josbert M. and Lammers, Twan},
  journal   = {Drug Delivery and Translational Research},
  year      = {2020},
  volume    = {10},
  number    = {3},
  pages     = {721--725},
  doi       = {10.1007/s13346-020-00740-5},
  url       = {https://doi.org/10.1007/s13346-020-00740-5}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201811
202088
20213737
20224141
20236767
20246262
2025100100
2026155155

Its field-weighted citation impact is 8.78: it has been cited 8.78 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • nanomedicine
  • clinical translation
  • drug development
  • clinical trial design
  • therapeutic endpoints
  • preclinical models
  • market opportunities
  • end-user perspective

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Metselaar, J. M., & Lammers, T. (2020). Challenges in nanomedicine clinical translation. Drug Delivery and Translational Research, 10(3), 721–725. https://doi.org/10.1007/s13346-020-00740-5

How many times has this paper been cited?

471 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Drug Delivery and Translational Research: sign in and open the PDF from this page.

Who wrote this paper?

Josbert M. Metselaar, Twan Lammers.

What is the DOI of this paper?

10.1007/s13346-020-00740-5, permanently at https://doi.org/10.1007/s13346-020-00740-5. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.